Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Cook Dr
Ste 203
Athens, TN 37303Phone+1 423-745-1411Fax+1 985-857-8902
Education & Training
UMass Chan Medical SchoolResidency, Internal Medicine, 1982 - 1983
Seth G.S. Medical CollegeClass of 1976
Certifications & Licensure
GA State Medical License 1981 - 2026
TN State Medical License 1983 - 2026
LA State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer Start of enrollment: 2012 Sep 01
- Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Start of enrollment: 2013 Apr 01
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 14 citationsPhase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.Richard Kim, E. Gabriela Chiorean, Manik Amin, Caio Rocha-Lima, Jitendra Gandhi
British Journal of Cancer. 2017-06-20 - 12 citationsPhase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.Daniel P. Petrylak, Jitendra G. Gandhi, William R. Clark, Elisabeth I. Heath, Jianqing Lin
Investigational New Drugs. 2015-01-04 - 17 citationsPhase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung CancerRamaswamy Govindan, Daniel Morgensztern, Michael D. Kommor, Roy S. Herbst, Paul Schaefer
Journal of Thoracic Oncology. 2011-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
